We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Baanx is a B2B2C mobile banking platform offering cutting-edge services in remittance, spending & blockchain. The company takes pride in its innovative customer acquisition process through partner communities. The BaanxCL already has a CL™ VISA Debit Card, Crypto-Payment Gateway, a Crypto-Exchange, Stablecoins, and other exciting features. The company is also partnering with new brands around the world which are not banking already but have large user communities to connect. The company is aiming to target 100,000 users by Q2 2020 with the assistance of Super Seed Investors. With the proceeds, Baanx will hire additional team members, spend funds on marketing, and launch services in South America and Asia.

Pitch Rated

49%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £658,200
CrowdProperty is a financial intermediation company that provides a P2P lending platform which facilitates loans between private individuals and UK professional property businesses. CrowdProperty believes in complete transparency and follows the principles and guidance of the Peer-To-Peer Finance Association (P2PFA). It is the only property development platform member of the P2PFA and the only to be Brismo (the leading provider of standardised loan performance data) verified. CrowdProperty has also financed the construction of over 500 Great British Homes, worth over £80,000,000 by lending over £30,000,000. CrowdProperty aims to secure the first place for strong first-charge secured returns for lenders and project finance direct to SME property professionals.
days to go: Expired investment: £1,098,832
Laka Insurance is a collective insurance provider. The company is disrupting the cycling and e-mobility industry. It aims to become a segment leader in the aforementioned industry that is forecast to reach £100 billion by 2025. Laka argues that the traditional insurance model is based on insurers taking a customer's money and profiting from not paying out claims. It aims to change this. Members on Laka share the cost of all claims, and the company earns its share when settling claims for the member. Laka has insured over 10,000 bikes till date. The company launched its new product, Laka Club, in 2020 that offers third-party liability insurance. Laka has won the Best Cycle Insurance Provider at the Insurance Choice Awards multiple times. The company will use the investment to expand its customer base, bring new offerings, and expand its business across different demographics.
days to go: Expired investment: £2,056,630
Easily understand and manage all your insurance in one simple app, ready for the digital age. Wrisk is all about transparency and allows customers to see how much they’re currently paying for their insurance, what actions they can take to reduce their risk and purchase the insurance seamlessly from within the app. Wrisk is seeking investment to expand and cater for as many insurance needs as possible. 
days to go: Expired investment: £1,044,630
Nude is a savings account and financial application designed for ~13 million 18-35-year-olds who want to own a home in the UK. The company is rebuilding the home-buying experience and assist its clients from planning to the move-in stage of home buying. The company has applied for a banking licence to launch Nude mortgages and plans to support people through all of life's big moments, like weddings, children's accounts and retirement plans as well. In 2019, Nude raised £1.7 million and was awarded an innovation grant of ~£440,000 from Scottish Enterprise. The company is registered with the Financial Conduct Authority(FCA) and has 7,500+ subscribers on its newsletter. It will use 50% of the investment to build its savings platform, 20% for operational costs, 20% in marketing initiatives, and 10% in building its data & behavioural science platform. 
days to go: Expired investment: £3,539,200
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph